A Randomized, Double-Blind, Placebo-Controlled, Multicentered Study to Evaluate the Efficacy and Safety of MEI005 in Reducing Submental Fat in Chinese Adults.
Abstract
[BACKGROUND] Submental fat (SMF) is a common aesthetic concern traditionally treated with liposuction. Nonsurgical alternatives, like injectable deoxycholic acid, are gaining popularity. However, no related products have been clinically approved in China.
[OBJECTIVES] This study evaluated the efficacy and safety of MEI005, a deoxycholic acid-based injectable formulation, in reducing SMF in Chinese adults.
[METHODS] This multicenter, randomized, double-blind, placebo-controlled Phase III trial included 325 Chinese adults with moderate-to-severe SMF. Participants received MEI005 or a placebo injection every 28 days for up to 6 sessions. Primary endpoints were ≥2-grade improvements in Clinician and Patient-Reported Submental Fat Rating Scales (CR-SMFRS and PR-SMFRS). Secondary endpoints included SMF volume reductions measured by MRI; patient-reported outcomes on the Patient-Reported Submental Fat Impact Scale (PR-SMFIS) and Subject Self-Rating Scale (SSRS); and SMF thickness reductions measured by caliper. Adverse events (AEs), self-reports, clinical examinations, and checks for skin laxity were monitored.
[RESULTS] At 12 weeks posttreatment, 18.9% of MEI005 recipients demonstrated simultaneously ≥2-grade CR-SMFRS and PR-SMFRS improvement vs 1.8% for placebo (P < .001). Additionally, 68.9% of MEI005 group participants achieved simultaneously ≥1-grade improvement in CR-SMFRS and PR-SMFRS, compared with 21.6% of placebo (P < .001). MRI revealed ≥10% SMF volume reduction in 50% of MEI005 patients vs 15.2% of placebo (P < .001). Scores on the PR-SMFIS and SSRSs showed greater psychological improvement and satisfaction among MEI005 recipients. Vernier caliper measurements showed a 21.42% thickness reduction vs 6.32% (P < .001). AEs were mostly mild to moderate.
[CONCLUSIONS] MEI005 effectively reduces SMF, offering a safe, minimally invasive option for Chinese adults.
[OBJECTIVES] This study evaluated the efficacy and safety of MEI005, a deoxycholic acid-based injectable formulation, in reducing SMF in Chinese adults.
[METHODS] This multicenter, randomized, double-blind, placebo-controlled Phase III trial included 325 Chinese adults with moderate-to-severe SMF. Participants received MEI005 or a placebo injection every 28 days for up to 6 sessions. Primary endpoints were ≥2-grade improvements in Clinician and Patient-Reported Submental Fat Rating Scales (CR-SMFRS and PR-SMFRS). Secondary endpoints included SMF volume reductions measured by MRI; patient-reported outcomes on the Patient-Reported Submental Fat Impact Scale (PR-SMFIS) and Subject Self-Rating Scale (SSRS); and SMF thickness reductions measured by caliper. Adverse events (AEs), self-reports, clinical examinations, and checks for skin laxity were monitored.
[RESULTS] At 12 weeks posttreatment, 18.9% of MEI005 recipients demonstrated simultaneously ≥2-grade CR-SMFRS and PR-SMFRS improvement vs 1.8% for placebo (P < .001). Additionally, 68.9% of MEI005 group participants achieved simultaneously ≥1-grade improvement in CR-SMFRS and PR-SMFRS, compared with 21.6% of placebo (P < .001). MRI revealed ≥10% SMF volume reduction in 50% of MEI005 patients vs 15.2% of placebo (P < .001). Scores on the PR-SMFIS and SSRSs showed greater psychological improvement and satisfaction among MEI005 recipients. Vernier caliper measurements showed a 21.42% thickness reduction vs 6.32% (P < .001). AEs were mostly mild to moderate.
[CONCLUSIONS] MEI005 effectively reduces SMF, offering a safe, minimally invasive option for Chinese adults.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | liposuction
|
지방흡입 | dict | 1 | |
| 해부 | Fat
|
scispacy | 1 | ||
| 해부 | skin
|
scispacy | 1 | ||
| 합병증 | Fat
|
scispacy | 1 | ||
| 약물 | SMF
→ Submental fat
|
scispacy | 1 | ||
| 약물 | deoxycholic acid
|
C0011479
deoxycholic acid
|
scispacy | 1 | |
| 약물 | deoxycholic acid-based
|
scispacy | 1 | ||
| 약물 | MEI005
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Submental
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | deoxycholic
|
scispacy | 1 | ||
| 약물 | PR-SMFIS
→ Patient-Reported Submental Fat Impact Scale
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] MEI005
|
scispacy | 1 | ||
| 질환 | SMF volume reductions
|
scispacy | 1 | ||
| 질환 | SMF
→ Submental fat
|
scispacy | 1 | ||
| 질환 | SSRS
→ Subject Self-Rating Scale
|
scispacy | 1 | ||
| 질환 | AEs
→ Adverse events
|
scispacy | 1 | ||
| 질환 | PR-SMFRS
|
scispacy | 1 | ||
| 기타 | SMF
→ Submental fat
|
scispacy | 1 | ||
| 기타 | recipients
|
scispacy | 1 | ||
| 기타 | participants
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | PR-SMFIS
→ Patient-Reported Submental Fat Impact Scale
|
scispacy | 1 | ||
| 기타 | SSRSs
|
scispacy | 1 |
MeSH Terms
Humans; Double-Blind Method; Female; Adult; Male; Deoxycholic Acid; Middle Aged; Subcutaneous Fat; China; Treatment Outcome; Injections, Subcutaneous; Magnetic Resonance Imaging; Patient Reported Outcome Measures; Young Adult; Chin; Cosmetic Techniques; Patient Satisfaction; East Asian People
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Quantitative Assessment of Cannula Kinematics in Liposuction Surgical Procedures Using a Marker-Based Tracking System.
- Fat harvesting protocol for enhanced stem cell viability - pilot study.
- Scarless Infragluteal Fixation (SIF): Correction of Post-Liposuction Infragluteal Deformity.
- [Super microsurgical lymphaticovenular anastomosis for limb lymphedema: An outcome analysis based on clinical stage and indocyanine green pattern].
- Iatrogenic pneumothorax associated with surgeries at anatomically thoracic-adjacent and non-adjacent sites: case report and scoping review.